169 related articles for article (PubMed ID: 35833537)
21. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G
J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848
[TBL] [Abstract][Full Text] [Related]
22. The miR-455-3p/HDAC2 axis plays a pivotal role in the progression and reversal of liver fibrosis and is regulated by epigenetics.
You H; Wang L; Bu F; Meng H; Pan X; Li J; Zhang Y; Wang A; Yin N; Huang C; Li J
FASEB J; 2021 Jul; 35(7):e21700. PubMed ID: 34105828
[TBL] [Abstract][Full Text] [Related]
23. Exogenous Therapeutics of Microrna-29a Attenuates Development of Hepatic Fibrosis in Cholestatic Animal Model through Regulation of Phosphoinositide 3-Kinase p85 Alpha.
Yang YL; Wang FS; Lin HY; Huang YH
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455716
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-29a mitigation of endoplasmic reticulum and autophagy aberrance counteracts in obstructive jaundice-induced fibrosis in mice.
Huang YH; Yang YL; Huang FC; Tiao MM; Lin YC; Tsai MH; Wang FS
Exp Biol Med (Maywood); 2018 Jan; 243(1):13-21. PubMed ID: 29105510
[TBL] [Abstract][Full Text] [Related]
25. miR-345-5p curbs hepatic stellate cell activation and liver fibrosis progression by suppressing hypoxia-inducible factor-1alpha expression.
Wang P; Fang Y; Qiu J; Zhou Y; Wang Z; Jiang C
Toxicol Lett; 2022 Nov; 370():42-52. PubMed ID: 36126797
[TBL] [Abstract][Full Text] [Related]
26. MiR-29a Assists in Preventing the Activation of Human Stellate Cells and Promotes Recovery From Liver Fibrosis in Mice.
Matsumoto Y; Itami S; Kuroda M; Yoshizato K; Kawada N; Murakami Y
Mol Ther; 2016 Oct; 24(10):1848-1859. PubMed ID: 27480597
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-21 activates hepatic stellate cells via PTEN/Akt signaling.
Wei J; Feng L; Li Z; Xu G; Fan X
Biomed Pharmacother; 2013 Jun; 67(5):387-92. PubMed ID: 23643356
[TBL] [Abstract][Full Text] [Related]
28. miR-324-3p Suppresses Hepatic Stellate Cell Activation and Hepatic Fibrosis Via Regulating SMAD4 Signaling Pathway.
Chen SY; Chen X; Zhu S; Xu JJ; Li XF; Yin NN; Xiao YY; Huang C; Li J
Mol Biotechnol; 2024 Feb; ():. PubMed ID: 38407690
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of microRNAs in bile duct obstruction-induced liver fibrosis and the identification of a novel liver fibrosis marker miR-1295b-3p.
Bu X; Ding W; Guo S; Wang Y; Feng J; Wang P; Chen Y; Ge Z
Ann Transl Med; 2023 Jan; 11(1):22. PubMed ID: 36760242
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-92b-3p promotes the progression of liver fibrosis by targeting CREB3L2 through the JAK/STAT signaling pathway.
Huang W; Ji R; Ge S; Zhou D; Liu Z; Sun Y; Huang W; Lu C
Pathol Res Pract; 2021 Mar; 219():153367. PubMed ID: 33618248
[TBL] [Abstract][Full Text] [Related]
31. Protective effect of Idelalisib on carbon tetrachloride-induced liver fibrosis via microRNA-124-3P/phosphatidylinositol-3-hydroxykinase signalling pathway.
Li X; Li H; Zhang S; Zhang R; Li J; Wei Y; Yang C; Zhang F; Zhou H
J Cell Mol Med; 2021 Dec; 25(24):11185-11197. PubMed ID: 34747105
[TBL] [Abstract][Full Text] [Related]
32. Mesenchymal stem cells improve liver fibrosis and protect hepatocytes by promoting microRNA-148a-5p-mediated inhibition of Notch signaling pathway.
Zhou Q; Rong C; Gu T; Li H; Wu L; Zhuansun X; Zhao X; Xiao Z; Kuang Y; Xu S; Wang S
Stem Cell Res Ther; 2022 Jul; 13(1):354. PubMed ID: 35883205
[TBL] [Abstract][Full Text] [Related]
33. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.
Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW
Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428
[TBL] [Abstract][Full Text] [Related]
34. Mesenchymal stem cell-originated exosomal circDIDO1 suppresses hepatic stellate cell activation by miR-141-3p/PTEN/AKT pathway in human liver fibrosis.
Ma L; Wei J; Zeng Y; Liu J; Xiao E; Kang Y; Kang Y
Drug Deliv; 2022 Dec; 29(1):440-453. PubMed ID: 35099348
[TBL] [Abstract][Full Text] [Related]
35. miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3.
Li R; Liu J; Li Q; Chen G; Yu X
Tumour Biol; 2016 Mar; 37(3):3987-96. PubMed ID: 26482618
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-503 Targets Mothers Against Decapentaplegic Homolog 7 Enhancing Hepatic Stellate Cell Activation and Hepatic Fibrosis.
Xie X; Dou CY; Zhou Y; Zhou Q; Tang HB
Dig Dis Sci; 2021 Jun; 66(6):1928-1939. PubMed ID: 32648079
[TBL] [Abstract][Full Text] [Related]
37. Repression of liver cirrhosis achieved by inhibitory effect of miR-454 on hepatic stellate cells activation and proliferation via Wnt10a.
Wang YZ; Zhang W; Wang YH; Fu XL; Xue CQ
J Biochem; 2019 Apr; 165(4):361-367. PubMed ID: 30535384
[TBL] [Abstract][Full Text] [Related]
38. Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition.
Chen Y; Ou Y; Dong J; Yang G; Zeng Z; Liu Y; Liu B; Li W; He X; Lan T
Exp Cell Res; 2018 Jan; 362(2):343-348. PubMed ID: 29196165
[TBL] [Abstract][Full Text] [Related]
39. Autophagy-Related Activation of Hepatic Stellate Cells Reduces Cellular miR-29a by Promoting Its Vesicular Secretion.
Yu X; Elfimova N; Müller M; Bachurski D; Koitzsch U; Drebber U; Mahabir E; Hansen HP; Friedman SL; Klein S; Dienes HP; Hösel M; Buettner R; Trebicka J; Kondylis V; Mannaerts I; Odenthal M
Cell Mol Gastroenterol Hepatol; 2022; 13(6):1701-1716. PubMed ID: 35219894
[TBL] [Abstract][Full Text] [Related]
40. Up-regulation of miR-200b in biliary atresia patients accelerates proliferation and migration of hepatic stallate cells by activating PI3K/Akt signaling.
Xiao Y; Wang J; Chen Y; Zhou K; Wen J; Wang Y; Zhou Y; Pan W; Cai W
Cell Signal; 2014 May; 26(5):925-32. PubMed ID: 24412919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
